extending the efficacy of levodopa in patients with parkinson’s disease
Published 1 year ago • 540 plays • Length 1:13Download video MP4
Download video MP3
Similar videos
-
2:35
levodopa dose adjustment versus adjunctive therapy in parkinson’s disease
-
2:37
long-term effectiveness of levodopa-carbidopa intestinal gel in parkinson's disease
-
2:20
phase ii study of ne3107 in levodopa/carbidopa-treated patients with parkinson's disease
-
9:31
challenges faced in early parkinson’s disease management and the resurgence of levodopa
-
0:50
subcutaneous levodopa/carbidopa infusion for parkinson's disease
-
1:20
foslevodopa/foscarbidopa improves nocturia symptoms in patients with parkinson’s disease
-
2:34
ongoing efforts to improve levodopa-based treatments in parkinson’s disease
-
4:39
levodopa and the pharmacological revolution in parkinson's disease
-
2:32
latest approaches to improve the delivery of levodopa
-
3:02
improvements to levodopa-based treatments for parkinson’s disease
-
3:32
adequately treating parkinson disease with levodopa
-
2:53
padova study: prasinezumab in patients with early parkinson's disease
-
1:44
bipark-i and ii: opicapone and levodopa in pd with motor fluctuations
-
18:15
long-acting, subcutaneous levodopa in parkinson's disease: is it safe?
-
34:13
parkinson's disease medications – making them work for you
-
38:05
parkinson's medications - part 1: levodopa
-
3:20
parkinson's disease: what’s to come in 2022?
-
11:04
will parkinson's disease therapy move past carbidopa-levodopa?
-
57:35
motor fluctuations and dyskinesia in parkinson's disease